Socioeconomic aspects of treatment of facial dyskinesias by botulotoxin A;SOCIOEKONOMICKE ASPEKTY TERAPIE FACIALNICH DYSKINEZI BOTULOTOXINEM A

Ceska a Slovenska Neurologie a Neurochirurgie

Volumn 59, Issue 3, 1996, Pages 148-151

  Kanovsky P ^a,b   Bares M ^a   Streitova H ^a   Pospisilova D ^a   Dufek, M ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Blepharospasm; Botulotoxin; Hemispasm

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; BLEPHAROSPASM; CLINICAL ARTICLE; DRUG COST; DRUG SAFETY; DYSKINESIA; FACE DYSKINESIA; FACE HEMISPASM; FEMALE; HUMAN; MALE; MUSCLE SPASM; SOCIOECONOMICS;

EID: 0029812262     PISSN: 12107859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Barrett, R. E., Yahr, M. D., Duvoisier, R. C.: Torsion dystonia and spasmodic torticollis: Results of treatment with L-Dopa, Neurology 1970; 20:107-113.
2. Jabbari, B., Scherohman, B., Gunderson, C. H., Rosenberg, M. L., Miller, J.: Treatment of Movement Disorders with Trihexphenidyl, Mov. Disord. 1989; 4:202-212.
3. Elston, J. S., Granje, F. C., Lees, A. J.: The relationship between eye - winking, tics, frequent eye - blinking and blepharospasm. J. Neurol. Neurosurg. Psych. 1989; 52:477-478.
4. Rondot, P., Bathien, N., Ziegler, M.: Bewegungsstoerungen in der Neurologie, Stuttgart: Enke Verlag, 1991:57-73.
5. Defazio, G., Liverea, P., Guanti, G.: Genetic contribution to adult - onset blepharospasm and cranial - cervical dystonia. Eur. Neurol. 1993; 33:345-350.
6. Grandas, F., Elston, J., Quinn, N., Marsden, C. D.: Blepharospasm: a review of 264 patients. J. Neurol. Neurosurg. Psych. 1988; 51:767-772.
7. Jankovic, J., Tolosa, E.: Blepharospasm and cranial-cervical dystonia, familiar occurence. Adv. Neurol. 1988; 49:117-123.
8. Moeller, A. R., Jannetta, P. J.: Physiological abnormalities in hemifacial spasm studied during microvascular decompression operation. Exp. Neurol. 1986; 93:584-600.
9. Saito, S., Moeller, A. R.: Chronic electrical stimulation of the facial nerve causes signs of facial nucleus hyperactivity, Neurol. Res. 1993; 15:225-231.
10. Scott, A. B., Rosenbaum, A., Collins, C. C.: Pharmacological weakening of extraocular muscles. Investigat. Ophthalm. Vis. Sci. 1973; 12:924-927.
11. Elston, J. S.: The management of blepharospasm and hemifacial spasm. J. Neurol. 1992; 39:5-8.
12. Elston, J. S: The clinical use of botulinum toxin. Sem. Ophthal. 1988; 3:249-260.
13. Elston, J. S., Ross Russell, R. W.: Effect of treatment with botulinum toxin on neurogenic blepharospasm. Brit. Med. J. 1985; 290:1857-1859.
14. Elston, J. S.: Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections. Brit. J. Opht. 1987; 71:664-668.
15. Jankovic, J., Schwartz, K., Donovan, D. T.: Botulinum toxin treatment of cranial - cervical dystonia, spasmodic dysphonia, other facial dystonias and hemifacial spasm. J. Neurol. Neurosurg. Psych. 1990; 53:633-639.
16. Valls-Sole, J., Tolosa, E., Ribega, G.: Neurophysiological observation on the effects of botulinum toxin treatment in patients with dystonic blepharospasm. J. Neurol. Neurosurg. Psych. 1991; 54:310-313.
17. Albanese, A., Colosimo, C., Carreta, D., Dickman, A., Bentivoglio, A. R.: Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm. Eur. Neurol. 1992; 32:112-117.
18. Ru̇žička, E., Roth, J., Diblík, P.: Botulotoxin v léčbě blefarospasmu. Čas. Lék. čes. 1992; 131:213-216.
19. Greene, P., Fahn, S.: Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A. Mov. Disord. 1993; 8:479-483.